Who David Fischel is
Fischel came to Stereotaxis as an investor and stayed to run it. He has been a director since leading an equity investment in September 2016 and chief executive and chairman since February 2017.1
Mathematics at UCLA and an MBA in Israel
Fischel earned a bachelor's degree in applied mathematics, magna cum laude, with a minor in accounting at the University of California, Los Angeles, and an MBA from Bar-Ilan University in Israel. He is a Certified Public Accountant, Chartered Financial Analyst, and Chartered Alternative Investment Analyst.1
Investing in medical devices
He started as a research analyst at SCP Vitalife, a healthcare venture capital fund. He then spent more than eight years as a principal and portfolio manager for medical device investments at DAFNA Capital Management, where he also worked on the firm's legal, accounting, IT, compliance, human resources, and marketing operations.1
Running Stereotaxis
Under Fischel, Stereotaxis has kept building on a technology that has treated more than 100,000 patients at over 100 hospitals. Revenue was $32.4 million in 2025, up 20%, and the company ended the year with $13.4 million in cash and no debt.2,3
Links
Sources
Photo: Stereotaxis press photo, published by Inside Precision Medicine, December 3, 2025.
